The billionaire Sackler family, who own OxyContin maker Purdue Pharma, has agreed to pay nearly $4.3 billion to resolve thousands of lawsuits accusing them of fueling the opioid crisis in the United States.
The huge payment from the Sacklers is part of a larger restructuring plan filed by Purdue on Monday night that intends to get the Connecticut-based pharmaceutical giant out of bankruptcy.
Purdue’s $10 billion plan to emerge from bankruptcy calls for it to be transformed into an entity that would see the Sacklers relinquish control of the company and steer revenue directly to plaintiffs.
The billion dollar contribution from the Sackler family, who have denied any wrongdoing, would see them freed from opioid-related litigation.
The plan was filed late on Monday night in US Bankruptcy Court in White Plains, New York after months of negotiations.
The nearly $4.3 billion payment from the Sackler family is part of a larger restructuring plan filed by Purdue on Monday night that intends to get the Connecticut-based pharmaceutical giant out of bankruptcy. Kathe Sackler and David Sackler are pictured during a congressional hearing before the House Oversight Committee last year
The Sacklers are one of the wealthiest families in the US. Pictured above is some of the Sackler family: Dr Richard Sackler, standing second from left and Jonathan Sackler standing second from right. Seated is Raymond and Beverly Sackler
Purdue had filed for bankruptcy back in September 2019 in the face of more than 2,900 lawsuits accusing the company of fueling the national opioid crisis through deceptive marketing.
The plan, which marks the company’s formal offer to settle the lawsuits, sets up trusts that would indirectly control the new entity to distribute money to states, local governments and tribal organizations for opioid abatement programs.
It also establishes trusts to pay out to private entities and individuals that have brought opioid-related lawsuits against Purdue, including hospitals, insurance carriers and legal guardians of children born with addiction-related issues.
In its proposal, the company said the Sackler family members would contribute nearly $4.3 billion over a decade, the company would kick in $500 million upfront and its sales would generate another $1 billion through the end of 2024.
The company says additional money would come from insurance claims.
Individual victims and their families would share $700 million to $750 million over time. With nearly 135,000 such claims, that would work out to average payments under $5,600. Personal injury payments are expected to range from $3,500 to $48,000.
The new entity will be overseen by a board comprising independent managers selected by states and local governments in consultation with Purdue and its unsecured creditors’ committee, according to its plan.
The Sacklers will not be part of that selection process.
Purdue said the new entity will not promote opioid products to healthcare providers.
The huge payment from the Sacklers is part of a larger restructuring plan filed by Purdue on Monday night that intends to get the Connecticut-based pharmaceutical giant (pictured above) out of bankruptcy
Purdue had filed for bankruptcy back in September 2019 in the face of more than 2,900 lawsuits accusing the company of fueling the national opioid crisis through deceptive marketing with its drug OxyContin
Most of Purdue’s plan is similar to what the company proposed a year and a half ago when it first sought bankruptcy protection – a move that halted lawsuits against both the company and Sackler family members.
The plan must receive approval from US Bankruptcy Judge Robert Drain in White Plains, New York.
Purdue initially had support from about half of the US states and other governmental entities for its proposed settlement.
Many other states have opposed Purdue’s plan, taking issue with the public trust arrangement and the size of the initial $3 billion contribution from the Sacklers, which they said should be larger.
‘The Sacklers became billionaires by causing a national tragedy. Now they’re trying to get away with it,’ Massachusetts Attorney General Maura Healey said in a statement.
‘We’re going to keep fighting for the accountability that families all across this country deserve.’
The true size of the family’s fortune is unclear.
An earlier court filing said family members received transfers of $12 billion to $13 billion from Purdue over the years, though a lawyer said much of that went to taxes or was reinvested in the company.
In letters to the US House Oversight Committee last week, the two branches of the family that own the company said the family members who were board members had net assets of far less – about $1.1 billion.
Complicated litigation continues to play out in courts across the country in efforts to hold the drug industry accountable, including in thousands of cases filed in federal court being overseen by one Cleveland-based judge. Purdue was removed from those cases and others when it filed for bankruptcy protection.
Trials in state and federal cases are scheduled to begin this year in California, New York, Ohio and West Virginia.
Separately, Purdue has pleaded guilty to federal criminal charges and settled civil complaints.
Purdue itself struck a deal with the Justice Department to pay $225 million toward a $2 billion criminal forfeiture.
The Justice Department agreed to forgo the rest if the company developed a reorganization plan that would establish a public benefit company or similar entity that would dedicate the remaining $1.775 billion to U.S. communities battling the opioid crisis.
The plan filed on Monday appears to comply with that.
In a separate federal deal announced at the same time, Sackler family members agreed to pay $225 million to the federal government but admitted no wrongdoing.
Purdue began selling OxyContin 25 years ago, encouraging doctors to drop long-held reservations about opioids and focus more on easing the pain of patients.
Court documents show company officials continued to push to maintain sales even as it became clear the drug was being abused.
More than 470,000 deaths in the US since 2000 have been linked to opioids, including both prescription drugs and illegal ones such as heroin and fentanyl.
The US topped 50,000 opioid-related overdose deaths for the first time in 2019 and several states last year reported a record pace of overdose deaths due to all drugs.